Direct acting antivirals are associated with more liver stiffness regression than pegylated interferon therapy in chronic hepatitis C patients.
Eman AbdelsameeaAyman AlsebaeyMohammed E Abdel SameaWael Abdel-RazekMohsen SalamaImam WakedPublished in: Expert review of anti-infective therapy (2020)
Treatment with DAAs is associated with fibrosis improvement more than treatment with PEG/RBV in chronic hepatitis C patients.